Experience
Alzheimer's Institute of America, Inc.
Avid Radiopharmaceuticals
Represented Avid in suit concerning amyloid beta technology and its use in animal models in searching for drugs to treat Alzheimer's disease (AD). Won a jury verdict for Avid on issue of inventorship and patent ownership that was affirmed by the Federal Circuit, and obtained a finding of exceptional case, entitling Avid to an award of attorneys' fees. The verdict disposed of a series of suits against numerous companies involved in scientific research relating to Alzheimer's disease.
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals, 2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals, 13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
Alzheimer's Institute of America, Inc. v. Eli Lilly and Company
Eli Lilly and Company
Paradox Security Systems, Ltd. v. ADT Security Services, Inc.
ADT Security Services, Inc.; Digital Security Controls
Rembrandt Patent Innovations, LLC and Rembrandt Secure Computing, LP v. Apple Inc.
Rembrandt Patent Innovations, LLC; Rembrandt Secure Computing
Interval Licensing LLC v. AOL, Inc.
AOL, Inc.
FIS successfully uses PTAB to invalidate quintessential “Business Method Patents”
Fidelity National Information Services, Inc. (FIS)
AstraZeneca Pharmaceuticals LP
Sun Pharmaceutical Inds. v. Eli Lilly and Co.
Eli Lilly and Company
Uniloc USA, Inc. et al v. Tencent America, LLC
Tencent America LLC
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.